483 Bioptron AG Nov 2017

483 Bioptron AG Nov 2017

Catherine Laufmann FDA$119.00 - Available Now

FDA investigators audited the Bioptron AG - Neuchatel, Switzerland facility and issued inspectional observations (via FDA 483) on 01 Nov 2017.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 01 Nov 2017
  • Location: Neuchatel, Switzerland
  • FEI: 3013929417
Add To Cart